Perbandingan Efektivitas Senam Etnis Batak Toba Dan Senam Tai Chi Terhadap Penurunan Kadar Gula Darah Pada Penderita Dm Tipe 2 Di Puskesmas Kabanjahe

Valentina Yovita Br Sitorus; Zesika Putri Br Simbolon

doi:10.62027/vitamedica.v4i3.912

Authors

Valentina Yovita Br Sitorus Universitas Prima Indonesia, Medan
Zesika Putri Br Simbolon Universitas Prima Indonesia, Medan

DOI:

https://doi.org/10.62027/vitamedica.v4i3.912

Keywords:

Type 2 Diabetes Mellitus, Fasting Blood Glucose, Batak Toba Ethnic Gymnastics, Tai Chi Gymnastics, Physical Activity

Abstract

Background: The increasing prevalence of Type 2 Diabetes Mellitus (DM) imposes significant health and economicburdens, necessitating effective, low-cost, and culturally acceptable non-pharmacological management approaches. Objective: To compare the effectiveness of Batak Toba Ethnic Gymnastics and Tai Chi Gymnastics in reducing fasting blood glucose levels among Type 2 DM patients at Kabanjahe Public Health Center. Methods: A quantitative study with quasi-experimental Two Group Pretest-Posttest Design was conducted. The sample consisted of 24 female Type 2 DM patients meeting inclusion criteria, divided equally into two intervention groups (12 respondents each). The intervention was performed for two weeks, three sessions per week (6 total sessions). Data were analyzed using Paired Sample T-Test and Independent Sample T-Test. Results: The Batak Toba Ethnic Gymnastics group experienced a mean reduction in fasting blood glucose of 37.92 mg/dL (from 179.92 mg/dL to 142.00 mg/dL; p = 0.000). The Tai Chi Gymnastics group showed a smaller reduction of 4.25 mg/dL (from 183.92 mg/dL to 179.67 mg/dL; p = 0.005). The Independent Sample T-Test confirmed a significant difference in effectiveness between the two groups (p = 0.000). Conclusion: Batak Toba Ethnic Gymnastics is proven to be far more effective in reducing fasting blood glucose levels compared to Tai Chi Gymnastics among Type 2 DM patients at Kabanjahe Public Health Center, likely due to its more dynamic, active movements and its cultural alignment with the local community.

References

Brannon, E. R., Piegols, L. D., Cady, G., Kupor, D., Chu, X., Guevara, M. V., Lima, M. R. N., Kanthi, Y., Pinsky, D. J., Uhrich, K. E., & Eniola-Adefeso, O. (2025). Polymerized Salicylic Acid Microparticles Reduce the Progression and Formation of Human Neutrophil Extracellular Traps (NET)s. Advanced Healthcare Materials, 14(5), 2400443. https://doi.org/10.1002/ADHM.202400443

Chen, Y., Lin, L., Xu, L., Jin, Q., Fu, W., Bai, Y., Huang, T., Gao, T., Wu, W., Xu, C., Wang, J., Zhang, L., Lv, Q., Yang, Y., Xie, M., & Dong, X. (2025). Platelet-mimicking nanoparticles loaded with diallyl trisulfide for Mitigating Myocardial Ischemia-Reperfusion Injury in rats. Colloids and Surfaces. B, Biointerfaces, 248. https://doi.org/10.1016/J.COLSURFB.2024.114460

Franchi, F., Schneider, D. J., Prats, J., Fan, W., Rollini, F., Been, L., Taatjes-Sommer, H. S., Bhatt, D. L., Deliargyris, E. N., & Angiolillo, D. J. (2022). Pharmacokinetic and pharmacodynamic profiles of a novel phospholipid-aspirin complex liquid formulation and low dose enteric-coated aspirin: results from a prospective, randomized, crossover study. Journal of Thrombosis and Thrombolysis, 54(3), 373–381. https://doi.org/10.1007/S11239-022-02687-5/FIGURES/4

Ghavimi, M. A., Bani Shahabadi, A., Jarolmasjed, S., Memar, M. Y., Maleki Dizaj, S., & Sharifi, S. (2020). Nanofibrous asymmetric collagen/curcumin membrane containing aspirin-loaded PLGA nanoparticles for guided bone regeneration. Scientific Reports 2020 10:1, 10(1), 18200-. https://doi.org/10.1038/s41598-020-75454-2

Guo, X., Hong, T., Zang, J., Shao, R., Hou, X., Wang, K., Liu, W., Su, F., & He, B. (2022). Thrombus-specific/responsive biomimetic nanomedicine for spatiotemporal thrombolysis and alleviation of myocardial ischemia/reperfusion injury. Journal of Nanobiotechnology, 20(1). https://doi.org/10.1186/S12951-022-01686-1

Han, H., Bártolo, R., Li, J., Shahbazi, M. A., & Santos, H. A. (2022). Biomimetic platelet membrane-coated nanoparticles for targeted therapy. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik e.V, 172, 1–15. https://doi.org/10.1016/J.EJPB.2022.01.004

Ji, M., Tang, Q., Olatunji, O. Y., Ge, R., Ying, Y., Pan, J., Yunusov, K. E., & Jiang, G. (2025). Platelet membrane-camouflaged bioactive glass nano-formulations for enhanced drug delivery in the treatment of acute arterial thrombosis. Acta Biomaterialia, 199, 324–336. https://doi.org/10.1016/J.ACTBIO.2025.04.036

Karam, M., Fahs, D., Maatouk, B., Safi, B., Jaffa, A. A., & Mhanna, R. (2022). Polymeric nanoparticles in the diagnosis and treatment of myocardial infarction: Challenges and future prospects. Materials Today. Bio, 14. https://doi.org/10.1016/J.MTBIO.2022.100249

Liu, H., Su, Y. Y., Jiang, X. C., & Gao, J. Q. (2022). Cell membrane-coated nanoparticles: a novel multifunctional biomimetic drug delivery system. Drug Delivery and Translational Research 2022 13:3, 13(3), 716–737. https://doi.org/10.1007/S13346-022-01252-0

Park, J. H., Jiang, Y., Zhou, J., Gong, H., Mohapatra, A., Heo, J., Gao, W., Fang, R. H., & Zhang, L. (2021). Genetically engineered cell membrane-coated nanoparticles for targeted delivery of dexamethasone to inflamed lungs. Science Advances, 7(25). https://doi.org/10.1126/SCIADV.ABF7820/ASSET/BE489537-CEEE-40AC-B825-ADF24A0B88C7/ASSETS/GRAPHIC/ABF7820-F5.JPEG

Pradhan, A., Tiwari, A., Caminiti, G., Salimei, C., Muscoli, S., Sethi, R., & Perrone, M. A. (2022). Ideal P2Y12 Inhibitor in Acute Coronary Syndrome: A Review and Current Status. International Journal of Environmental Research and Public Health, 19(15). https://doi.org/10.3390/IJERPH19158977

Song, Y., Huang, Z., Liu, X., Pang, Z., Chen, J., Yang, H., Zhang, N., Cao, Z., Liu, M., Cao, J., Li, C., Yang, X., Gong, H., Qian, J., & Ge, J. (2019). Platelet membrane-coated nanoparticle-mediated targeting delivery of Rapamycin blocks atherosclerotic plaque development and stabilizes plaque in apolipoprotein E-deficient (ApoE−/−) mice. Nanomedicine: Nanotechnology, Biology and Medicine, 15(1), 13–24. https://doi.org/10.1016/J.NANO.2018.08.002

Su, T., Huang, K., Ma, H., Liang, H., Dinh, P. U., Chen, J., Shen, D., Allen, T. A., Qiao, L., Li, Z., Hu, S., Cores, J., Frame, B. N., Young, A. T., Yin, Q., Liu, J., Qian, L., Caranasos, T. G., Brudno, Y., … Cheng, K. (2019). Platelet-Inspired Nanocells for Targeted Heart Repair After Ischemia/Reperfusion Injury. Advanced Functional Materials, 29(4). https://doi.org/10.1002/ADFM.201803567

Wang, B., Chen, G., Urabe, G., Xie, R., Wang, Y., Shi, X., Guo, L. W., Gong, S., & Kent, K. C. (2018). A paradigm of endothelium-protective and stent-free anti-restenotic therapy using biomimetic nanoclusters. Biomaterials, 178, 293–301. https://doi.org/10.1016/J.BIOMATERIALS.2018.06.025

Wang, S., Duan, Y., Zhang, Q., Komarla, A., Gong, H., Gao, W., & Zhang, L. (2020). Drug Targeting via Platelet Membrane-Coated Nanoparticles. Small Structures, 1(1), 2000018. https://doi.org/10.1002/SSTR.202000018

Wang, S., Wang, R., Meng, N., Guo, H., Wu, S., Wang, X., Li, J., Wang, H., Jiang, K., Xie, C., Liu, Y., Wang, H., & Lu, W. (2020). Platelet membrane-functionalized nanoparticles with improved targeting ability and lower hemorrhagic risk for thrombolysis therapy. Journal of Controlled Release : Official Journal of the Controlled Release Society, 328, 78–86. https://doi.org/10.1016/J.JCONREL.2020.08.030

Wei, Q., Xiao, Y., Du, L., & Li, Y. (2024). Advances in Nanoparticles in the Prevention and Treatment of Myocardial Infarction. Molecules 2024, Vol. 29, Page 2415, 29(11), 2415. https://doi.org/10.3390/MOLECULES29112415

Yaman, S., Chintapula, U., Rodriguez, E., Ramachandramoorthy, H., & Nguyen, K. T. (2020). Cell-mediated and cell membrane-coated nanoparticles for drug delivery and cancer therapy. Cancer Drug Resist 2020;3:879-911., 3(4), 879–911. https://doi.org/10.20517/CDR.2020.55

Zhang, Z., Chen, Z., Yang, L., Zhang, J., Li, Y., Li, C., Wang, R., Wang, X., Huang, S., Hu, Y., Shi, J., & Xiao, W. (2022). Platelet Membrane–Encapsulated MSNs Loaded with SS31 Peptide Alleviate Myocardial Ischemia-Reperfusion Injury. Journal of Functional Biomaterials, 13(4), 181. https://doi.org/10.3390/JFB13040181/S1

Zhao, Y., Xie, R., Yodsanit, N., Ye, M., Wang, Y., Wang, B., Guo, L. W., Kent, K. C., & Gong, S. (2021). Hydrogen peroxide-responsive platelet membrane-coated nanoparticles for thrombus therapy. Biomaterials Science, 9(7), 2696–2708. https://doi.org/10.1039/D0BM02125C

Zhou, X., Angiolillo, D. J., & Ortega-Paz, L. (2022). P2Y12 Inhibitor Monotherapy after Percutaneous Coronary Intervention. Journal of Cardiovascular Development and Disease, 9(10), 340. https://doi.org/10.3390/JCDD9100340/S1

Zhu, C., Ma, J., Ji, Z., Shen, J., & Wang, Q. (2021). Recent Advances of Cell Membrane Coated Nanoparticles in Treating Cardiovascular Disorders. Molecules, 26(11), 3428. https://doi.org/10.3390/MOLECULES26113428.